H.B. Fuller Company reported a net revenue of $950.3 million for the second quarter of 2026, marking a 5.8% increase from $898.1 million in the same period last year. For the first six months of 2026, the company achieved net revenue of $1.721 billion, a 2.0% rise compared to $1.687 billion in the first half of 2025. The growth in revenue was attributed to a combination of a 3.1% positive impact from currency fluctuations, a 3.0% increase in pricing, and a 0.1% contribution from acquisitions, although this was partially offset by a 0.4% decline in sales volume.
The company's gross profit for the second quarter increased to $319.7 million, up 11.6% from $286.4 million a year earlier, with a gross profit margin improvement of 170 basis points. For the first half of 2026, gross profit rose to $555.7 million, an 8.2% increase from $513.5 million in the prior year. The increase in gross profit margin was primarily driven by higher product pricing and the effects of restructuring actions, despite rising manufacturing and distribution costs.
In terms of profitability, H.B. Fuller reported a net income attributable to the company of $67.8 million for the second quarter of 2026, a significant increase from $41.8 million in the same quarter of 2025. For the first six months, net income rose to $88.9 million from $55.1 million year-over-year. Diluted earnings per share for the second quarter were $1.23, compared to $0.76 in the previous year, while for the first half, it was $1.61, up from $0.99.
Strategically, H.B. Fuller has been active in expanding its portfolio through acquisitions. The company completed the acquisition of ND Industries Turkey in November 2025 and ND Industries Taiwan in February 2025, both aimed at enhancing its presence in high-growth markets. Additionally, the company announced a recommended cash offer for Advanced Medical Solutions Group plc, valued at approximately £659 million, which is expected to close by the end of the calendar year, pending regulatory approvals.
Operationally, H.B. Fuller reported a total employee headcount of 6,800 as of May 30, 2026, reflecting ongoing restructuring efforts aimed at optimizing operations. The company has also been focusing on improving its cash flow, with net cash provided by operating activities reaching $117.2 million in the first half of 2026, compared to $57.8 million in the same period of 2025. Looking ahead, H.B. Fuller anticipates continued growth driven by strategic acquisitions and operational efficiencies, although it remains cautious of market conditions and potential impacts on sales volume.
About FULLER H B CO
H.B. Fuller is a global manufacturer and marketer of adhesives, sealants, and specialty chemicals. Its core segments include Hygiene, Health and Consumable Adhesives, Engineering Adhesives, and Construction Adhesives. Serving diverse markets such as consumer goods, construction, automotive, aerospace, and electronics, the company emphasizes innovation, quality, and customer relationships across 35 countries, supporting sustainable growth through research, compliance, and operational excellence.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.